(NP (NP (NP-COOD (NP (NN Cloning)) (CC and) (NP (NN expression))) (PP (IN of) (NP (DT the) (ADJP (JJ Epstein-Barr) (JJ virus-encoded)) (NN dUTPase))) (: :)) (S (NP-SBJ (NP (NNS patients)) (PP (IN with) (NP (ADJP-COOD (ADJP (JJ acute)) (, ,) (ADJP (VBN reactivated)) (CC or) (ADJP (JJ chronic))) (NN virus) (NN infection)))) (VP (VBP develop) (NP (NP (NNS antibodies)) (PP (IN against) (NP (DT the) (NN enzyme))))) (. .)))
(S (NP-SBJ-74 (NP (DT The) (NN gene)) (VP (VBG encoding) (NP (DT the) (ADJP (NP (JJ Epstein-Barr) (NN virus)) (-LRB- -LRB-) (NN EBV) (-RRB- -RRB-) (JJ -specific)) (NN dUTPase)))) (VP (VBD was) (VP (VBN amplified) (NP (-NONE- *-74)) (PP (IN from) (NP (NN virus) (NN DNA))) (PP (IN by) (NP-LGS (NN PCR))))) (. .))
(S (NP-SBJ-75 (DT The) (JJ active) (NN enzyme)) (VP (VBD was) (VP (VBN expressed) (NP (-NONE- *-75)) (PP-COOD (PP (IN in) (NP (FW Escherichia) (FW coli))) (CC and) (PP (IN in) (NP (NN insect) (NNS cells)))) (PP (IN as) (NP (DT a) (JJ non-fusion) (NN protein))))) (. .))
(S (NP-SBJ (NP (DT The) (NN protein)) (PP (IN from) (NP (FW E.) (FW coli)))) (ADVP (RB specifically)) (VP-COOD (VP (VBD converted) (NP (NN dUTP)) (PP (TO to) (NP (NN dUMP)))) (CC and) (VP (VBD did) (RB not) (VP (VB react) (PP (IN with) (NP (JJ other) (NP-COOD (NP (NNS dNTPs)) (CC or) (NP (NNS NTPs)))))))) (. .))
(S (NP-SBJ (JJ Preliminary) (NNS experiments)) (VP (VBD yielded) (NP (NP (DT a) (NN Km) (NN value)) (PP (IN of) (NP (QP (RB about) (CD 0.8)) (NN microM)))) (PP (IN for) (NP (NN dUTP)))) (. .))
(S (NP-SBJ (NP (NNS MAbs)) (PP (IN against) (NP (DT the) (NN dUTPase)))) (VP (VBD reacted) (PP (IN with) (NP (NP (DT a) (NN protein)) (PP (IN of) (NP (QP (RB approximately) (CD 31)) (NN kDa))) (PP (IN in) (NP (NP (ADJP (NP (NN 12-O-tetradecanoyl-phorbol-13-acetate)) (-LRB- -LRB-) (NN TPA) (-RRB- -RRB-) (JJ -stimulated)) (NN B) (NNS cells)) (VP (VBG harbouring) (NP (NP-COOD (CC either) (NP (NN type) (CD 1)) (CC or) (NP (NN type) (CD 2))) (NN EBV)))))))) (. .))
(S-COOD (S (NP-SBJ-76 (DT The) (NN protein)) (VP (VBD was) (VP (VBN found) (NP (-NONE- *-76)) (PP (IN in) (NP (JJ untreated) (NNS cells))) (PP (IN at) (NP (JJ low) (NNS levels)))))) (, ,) (IN whereas) (S (NP-SBJ (NP (NN induction)) (PP (IN of) (NP (DT the) (JJ lytic) (NN replication) (NN cycle))) (PP-COOD (PP (IN by) (NP (NN TPA) (NN treatment))) (CC or) (PP (IN by) (S (NP-SBJ (-NONE- *)) (VP (VBG providing) (NP (DT the) (JJ immediate) (JJ early) (NN transactivator) (NN BZLF1)))))) (PP (IN in) (NP (NN trans)))) (VP (VBD resulted) (PP (IN in) (NP (VBN increased) (NN expression))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN virus) (NN dUTPase)) (VP (VBN isolated) (NP (-NONE- *)) (PP (IN from) (NP (JJ EBV-infected) (NNS cells))))) (VP (VBZ is) (NP-PRD (DT a) (NN phosphoprotein)))))) (. .))
(S (NP-SBJ-77 (NP (DT The) (NN protein)) (VP (VBN expressed) (NP (-NONE- *)) (PP (IN in) (NP (NN insect) (NNS cells))))) (VP (VBD was) (VP (VBN used) (NP (-NONE- *-77)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB test) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ specific) (NNS antibodies))) (PP (IN in) (NP (NP (NN sera)) (PP-COOD (PP (IN from) (NP (ADJP-COOD (ADJP (JJ normal)) (, ,) (ADJP (JJ healthy))) (NNS carriers))) (CC and) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ various) (NNS diseases))))))))))))))) (. .))
(S (SBAR (IN While) (S (NP-SBJ (NP (DT the) (NN sera)) (PP (IN of) (NP-COOD (NP (NP (JJ EBV-negative) (NNS individuals)) (PRN (-LRB- -LRB-) (NP (CD (3 0))) (-RRB- -RRB-))) (CC or) (NP (NP (JJ healthy) (NNS carriers)) (PRN (-LRB- -LRB-) (NP (CD (33 0))) (-RRB- -RRB-)))))) (VP (VBD did) (RB not) (VP (VB contain) (NP (NP (JJ detectable) (NNS levels)) (PP (IN of) (NP (NNS antibodies)))))))) (, ,) (NP-SBJ (NP (NNS patients)) (PP (IN with) (NP-COOD (NP (NP (NN mononucleosis)) (PRN (-LRB- -LRB-) (NP (CD (18 5))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ chronic) (NN EBV) (NN infection)) (PRN (-LRB- -LRB-) (NP (CD (7 2))) (-RRB- -RRB-))) (, ,) (NP (NP (NN EBV) (NN reactivation)) (PRN (-LRB- -LRB-) (NP (CD (20 7))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (NN infection)) (PRN (-LRB- -LRB-) (NP (CD (24 5))) (-RRB- -RRB-)))))) (VP (VBD showed) (NP (NP (JJ elevated) (NN antibody) (NNS titres)) (PP (IN against) (NP (DT the) (NN enzyme))))) (. .))
(S (NP-SBJ (DT This)) (VP (VBD indicated) (SBAR (IN that) (S (NP-SBJ-78 (DT the) (NN dUTPase)) (VP (VBZ is) (VP (VBN expressed) (NP (-NONE- *-78)) (PP-TMP (IN during) (NP (NN EBV) (NP-COOD (NP (NN replication)) (CC and) (NP (NN reactivation)))))))))) (. .))
(S (NP-SBJ (DT The) (NN enzyme)) (VP (MD might) (ADVP (RB therefore)) (VP (VB be) (NP-PRD (NP (DT a) (JJ potential) (NN target)) (PP (IN for) (NP (NN drug) (NN therapy)))) (PP (IN under) (NP (NP (NNS conditions)) (PP (IN of) (NP (JJ active) (NN DNA) (NN replication))))))) (. .))
